A once daily, oral, triple combination of BTK inhibitor, mTOR inhibitor and IMiD for treatment of relapsed/refractory Richter's transformation and de novo diffuse large B-cell lymphoma Meeting Abstract
| Authors: | Mato, A. R.; Schuster, S. J.; Foss, F. M.; Isufi, I.; Kothari, S. K.; Ding, W.; Brander, D. M.; Sitlinger, A.; Rosenthal, A. C.; Leis, J. F.; Tun, H. W.; Kennard, K.; Nelson, A. R.; Falco, V.; Komari, C. J.; Koehler, A. B.; Stowe, R.; He, W.; Kearney, A.; Gui, M.; McKinlay, T.; Roeker, L. E.; Thompson, M. C.; Huntington, S. F. |
| Abstract Title: | A once daily, oral, triple combination of BTK inhibitor, mTOR inhibitor and IMiD for treatment of relapsed/refractory Richter's transformation and de novo diffuse large B-cell lymphoma |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547201144 |
| DOI: | 10.1182/blood-2020-138896 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 21 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work